Related Experiment Video
Updated: Jan 5, 2026

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Evaluation of linearity in the clinical laboratory
Jeffrey S Jhang1, Chung-Che Chang, Daniel J Fink
1College of Physicians and Surgeons of Columbia University, New York, NY, USA.
Context:
Clinical laboratory assessment of test linearity is often limited to satisfying regulatory requirements rather than integrating this tool into the laboratory quality assurance program. Although an important part of quality control and method validation for clinical laboratories, linearity of clinical tests does not get the attention it deserves.
Objective:
This article evaluates the concepts and importance of linearity evaluations for clinical tests.
Design:
We describe the theory and procedural steps of each linearity evaluation. We then evaluate the statistical methods for each procedure.
Results:
Visual assessment, although simple, is subjective. The lack-of-fit error and the 1986 NCCLS EP6-P G test are sensitive to imprecision and assume that the data are first order. Regression analysis, as developed as the polynomial method, is partly based on the experiences of the College of American Pathologists Instrumentation Resource Committee and has proved to be a robust statistical method.
Conclusions:
We provide general guidelines for handling non-linear results from a linearity evaluation. Handling linearity data in an objective manner will aid clinical laboratorians whose goal is to improve the quality of the tests they perform.
Related Concept Videos
Data Validation
Key parameters for method validation include:
Calibration Curves: Linear Least Squares
For data that follow a straight line, the standard method for fitting is the linear...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
Linear Circuits
Nonlinear Pharmacokinetics: Causes of Nonlinearity
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...

